Cargando…
Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor(®) EL
BACKGROUND: Ciclosporin is used as an immunosuppressant in current clinical practice but recent research implies novel indications for the drug, such as neuro- and cardioprotection. The intravenous formulation currently on the market, Sandimmune(®) Injection (Sandimmune(®)), uses Cremophor(®) EL as...
Autores principales: | Ehinger, Karl Henrik Johannes, Hansson, Magnus Joakim, Sjövall, Fredrik, Elmér, Eskil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing AG
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586182/ https://www.ncbi.nlm.nih.gov/pubmed/23179472 http://dx.doi.org/10.1007/s40261-012-0029-x |
Ejemplares similares
-
Erratum to: Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor(®) EL
por: Ehinger, Karl Henrik Johannes, et al.
Publicado: (2013) -
Copenhagen Head Injury Ciclosporin Study: A Phase IIa Safety, Pharmacokinetics, and Biomarker Study of Ciclosporin in Severe Traumatic Brain Injury Patients
por: Kelsen, Jesper, et al.
Publicado: (2019) -
Ciclosporin 10 years on: indications and efficacy
por: Forsythe, Peter, et al.
Publicado: (2014) -
Ciclosporin: Various toxicities: case report
Publicado: (2022) -
Ciclosporin to Protect Renal function In Cardiac Surgery (CiPRICS): a study protocol for a double-blind, randomised, placebo-controlled, proof-of-concept study
por: Ederoth, Per, et al.
Publicado: (2016)